A novel halogenated adenosine analog 5’-BrDA displays potent toxicity against colon cancer cells in vivo and in vitro

Adenosine, as a naturally occurring nucleoside , plays an important role in human health maintenance. In recent years, many studies have shown that adenosine has the effect of cancer inhibition, and some of its analogs have been successfully marketed as anticancer drugs . This report mainly describes the anti-colon cancer activities and mechanism of a novel halogenated adenosine analog named 5′-bromodeoxyadenosine (5’-BrDA). As a result, 5’-BrDA concentration-dependently inhibited colon cancer cells proliferation , induced autophagy without disruption of lysosomal stability, and promoted autophagy-independently cellular mitochondrial apoptosis by increasing the accumulation of reactive oxygen species . Furthermore, 5’-BrDA inhibited the tumor growth of colon cancer in CT26 inbred mice without affecting the body weight in vivo . Collectively, the above-mentioned mechanisms contributed to the anticancer activity of 5’-BrDA. It is rare to discover novel anticancer adenosine analogs during the past couple of decades. We believe that our work will enrich the understanding of adenosine analogs, also, pave the way for adenosine analogs product based anticancer drug development.